Healthcare Services

Biopharmaceutical CMO And CRO Market Forecast 2026–2035 Reflecting Expansion Opportunities Across Industries

March 30, 2026March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Biopharmaceutical CMO And CRO Market From 2026 To 2030?

The biopharmaceutical contract manufacturing organization (CMO) and contract research organization (CRO) market has experienced robust expansion in recent times. This market is projected to expand from $35.6 billion in 2025 to $38.01 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 6.8%. Historically, this growth has been driven by factors such as the increasing intricacy of developing biologic drugs, escalating research and development (R&D) expenses for biopharmaceutical firms, the broadening of clinical trial operations, the surge in biosimilar product development, and the presence of dedicated contract service providers.

The biopharmaceutical cmo and cro market is projected to experience substantial expansion in the coming years. By 2030, its size is anticipated to reach $48.79 billion, demonstrating a compound annual growth rate (CAGR) of 6.4%. This projected growth is driven by several factors, including a heightened demand for advanced biologics production, increased investments in cell and gene therapies, the expansion of global clinical trial pipelines, a greater emphasis on strategies for faster market entry, and the increasing uptake of digitalized CRO services. Key trends for the forecast period encompass a rise in the outsourcing of biologic drug manufacturing, a growing need for comprehensive end-to-end contract research services, an increased focus on adaptable manufacturing capabilities, expanded support for cell and gene therapy development, and a stronger emphasis on regulatory compliance assistance.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19337&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Biopharmaceutical CMO And CRO Market?

Increased spending on research and development is projected to boost the expansion of the biopharmaceutical CMO and CRO market in the coming period. Such investments in R&D are escalating due to several reasons, including the demand for innovation, competitive pressures, the necessity to address evolving market requirements, and government incentives. Research and development funding empowers CMOs and CROs to develop advanced manufacturing methods and research protocols, thereby enhancing their capabilities and operational effectiveness. This commitment to innovation attracts and retains clients by delivering cutting-edge solutions while consistently ensuring regulatory compliance. For instance, Eurostat, the Luxembourg-based statistical agency, indicated in September 2025 that the EU spent approximately $456 billion USD on research and development (R&D) in 2023 (€389 billion), with R&D expenditure relative to GDP rising to 2.26%, up from 2.22% in the preceding year. Hence, the growing investment in research and development is fueling the growth of the biopharmaceutical CMO and CRO market.

Which Segments Are Included In The Analysis Of The Biopharmaceutical CMO And CRO Market?

The biopharmaceutical cmo and cro market covered in this report is segmented –

1) By Product: Biologics, Biosimilars

2) By Service Type: Contract Manufacturing, Contract Research

3) By Source: Mammalian, Non-Mammalian

Subsegments:

1) By Biologics: Monoclonal Antibodies (mAbs), Vaccines, Recombinant Proteins, Cell and Gene Therapies, Antibody-Drug Conjugates (ADCs), Therapeutic Enzymes

2) By Biosimilars: Biosimilar Monoclonal Antibodies, Biosimilar Insulins, Biosimilar Growth Hormones, Biosimilar Erythropoietins, Biosimilar Granulocyte Colony-Stimulating Factors (G-CSFs)

What Trends Are Affecting The Expansion Of The Biopharmaceutical CMO And CRO Market?

Leading companies within the biopharmaceutical CMO and CRO market are forming strategic alliances to bolster services, improve operational efficiencies, and accelerate the drug development process for biopharmaceutical firms. Strategic partnerships involve companies utilizing each other’s strengths and resources to achieve mutual benefits and success. As an illustration, in June 2024, Abzena plc., a UK-based biopharmaceutical company, collaborated with Argonaut Manufacturing Services Inc., a US-based contract manufacturing organization (CMO), to integrate drug development and manufacturing solutions for clients. Through this partnership, they aim to provide accelerated, end-to-end drug development and manufacturing solutions that enhance efficiency, reduce costs, and streamline biopharmaceutical production for clients.

Which Key Industry Participants Are Active In The Biopharmaceutical CMO And CRO Market?

Major companies operating in the biopharmaceutical cmo and cro market are Thermo Fisher Scientific Inc., Boehringer Ingelheim International GmbH, Eurofins Scientific SE, Lonza Group AG, Syneos Health Inc., Catalent Inc., Charles River Laboratories International Inc., Parexel International (MA) Corporation, Samsung Biologics Co. Ltd., CELLTRION INC., Medpace Holdings Inc., Fujifilm Diosynth Biotechnologies UK Limited, Almac Group, Pharmaron Beijing Co. Ltd., Worldwide Clinical Trials, KBI Biopharma, Inotiv Inc., Caidya, Rentschler Biopharma SE, Celerion Inc., TFS HEALTHCARE LIMITED

Read the full biopharmaceutical cmo and cro market report here:

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-cmo-and-cro-global-market-report

What Are The Leading Geographic Regions In The Biopharmaceutical CMO And CRO Market?

North America was the largest region in the biopharmaceutical CMO and CRO market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical cmo and cro market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Biopharmaceutical CMO And CRO Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19337&type=smp

Browse Through More Reports Similar to the Global Biopharmaceutical CMO And CRO Market 2026, By The Business Research Company

Medical Biomimetics Global Market Report

https://www.thebusinessresearchcompany.com/report/medical-biomimetics-global-market-report

Biosimilar Global Market Report

https://www.thebusinessresearchcompany.com/report/biosimilar-global-market-report

Pharmaceuticals Market

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795